Published in Horm Metab Res on January 01, 1999
Hypothalamic mechanisms of ageing and of specific age pathology--II. on the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis. Exp Gerontol (1979) 1.39
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Glucose-induced effects and joker function of glucose: endocrine or genotoxic prevalence? Horm Metab Res (2006) 0.99
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol (2003) 0.94
Preliminary evidence on metabolic rehabilitation of cancer patients. Arch Geschwulstforsch (1988) 0.91
CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol (2001) 0.87
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma (1997) 0.79
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol (2000) 0.77
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76
[Biodistribution of the recombinant heat shock protein rhHsp70 in intracranial C6 glioma models in Wistar rats and subcutaneos B16/F10 melanoma in C57BL/6 mice]. Vopr Onkol (2013) 0.76
[Cognitive function in patients with endometrial and colorectal cancer: connection with hormonal and metabolic status]. Vopr Onkol (2004) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences. Eur J Gynaecol Oncol (1993) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
[Features of carcinogenesis and aging in knockout male mice PARP-1]. Vopr Onkol (2010) 0.76
Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione. Int J Cancer (1998) 0.76
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. Mutat Res (1996) 0.75
Professor Vladimir Dilman. Int J Obes Relat Metab Disord (1995) 0.75
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
[Work conditions and the state of individual physiological functions in women telephone operators in an information referral service]. Gig Tr Prof Zabol (1973) 0.75
[Comparison of letrozole and exemestane used in non-adjuvant therapy of endometrial carcinoma]. Vopr Onkol (2005) 0.75
[Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Vopr Onkol (1998) 0.75
[Specifics of metabolic disorders in patients with "hormone-associated neoplastic" syndromes]. Vopr Onkol (1996) 0.75
[Comparative characteristics of hormonal status in patients with receptor-negative cancers of the breast and of the endometrium]. Vopr Onkol (2003) 0.75
[Gail's coefficient in breast cancer patients with respect to menstrual status, body mass and estrogen receptor pattern of tumor]. Vopr Onkol (2004) 0.75
[Microviscosity of erythrocyte membranes in breast cancer patients: connection with the receptor phenotype of the tumor]. Vopr Onkol (2014) 0.75
[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75
Effect of ethanol on uterotropic action of estrogens. Bull Exp Biol Med (2000) 0.75
[Industrial hygiene requirements for working with microfilm]. Gig Sanit (1970) 0.75
[Endocrine-genotoxic switchings as promoter of main noninfectious diseases]. Vestn Ross Akad Med Nauk (2008) 0.75
[Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives]. Vopr Onkol (2010) 0.75
[Effect of tobacco smoke on the level of estrogens and DNA in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
[Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features]. Vopr Onkol (2008) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75
[Lipoprotein lipase: properties, change in activity with age and in some noninfectious human diseases]. Vopr Med Khim (1997) 0.75
[Estrogen-dependent peroxidase and hormone-dependent carcinogenesis]. Vopr Onkol (1999) 0.75
[Estrogen-dependence of thyroid carcinoma: testing with estradiol preparations and tamoxifen]. Vopr Onkol (2008) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75
[Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer]. Vopr Onkol (2008) 0.75
[Physiologico-hygienic assessment of visual work in reading microfilm]. Gig Tr Prof Zabol (1968) 0.75
[Hormonal and progenotoxic properties of mammary fat in pre- and postmenopausal cancer patients]. Vopr Onkol (2006) 0.75
[Decrease of testosterone level in blood of breast cancer patients of reproductive age after neoadjuvant chemotherapy]. Vopr Onkol (2012) 0.75
[Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer]. Vopr Onkol (1996) 0.75
[Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer]. Vopr Onkol (2007) 0.75
[Catecholestrogens: synthesis, properties and role in carcinogenesis]. Vopr Onkol (1997) 0.75
[The correlation between the indices of lipid metabolism and of thrombocyte function determined by statometry]. Fiziol Cheloveka (1990) 0.75
[Protocol of the 500th jubilee meeting of the Society of Oncologists, devoted to the theme of "Hormone-dependent tumors -- pathogenesis and therapy," May 12, 2014]. Vopr Onkol (2014) 0.75
Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. Bull Exp Biol Med (2005) 0.75
Influence of tobacco smoke on DNA unwinding and uterotrophic effect of estrogens in rats. Cancer Lett (1998) 0.75
Modification of the uterotropic effect produced by estrogens in aging rats. Bull Exp Biol Med (2002) 0.75
[Age-related changes in the reaction of the adrenal cortex to surgical stress in cancer patients]. Vopr Onkol (1992) 0.75
[Somatomedin activity of the blood: hormonal metabolic and immunological shifts in cancer patients]. Vopr Onkol (1988) 0.75
[Lipid metabolic disorders in rats with a transplanted Pliss lymphosarcoma]. Eksp Onkol (1986) 0.75
[Blood insulin and insulin sensitivity in breast cancer patients of various ages: the effect of smoking]. Vopr Onkol (1998) 0.75
Modification of uterotropic effect of estrogens by whole-body gamma-irradiation. Bull Exp Biol Med (2001) 0.75
[Switching off the estrogen effect and approaches to its correction]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
Expression of estrogen receptors-beta and aromatase activity in primary mammary gland tumors. Bull Exp Biol Med (2003) 0.75
[Adipose and lean body mass in obese pre- and post-menopausal patients with breast cancer: the modifying role of smoking]. Vopr Onkol (1994) 0.75
[Body weight, blood lipids, blood cortisol and prognosis of patients with cancer of the large intestine and breast]. Vopr Onkol (1989) 0.75
[Correlation of hormone-metabolic status in breast cancer and effectiveness of adjuvant hormone therapy]. Vopr Onkol (2006) 0.75
[Physiological and hygienic characteristics of visual work performed by stereophotogrammetry operators]. Gig Tr Prof Zabol (1973) 0.75
[Family diabetes and its consequences in cancer patients]. Vopr Onkol (2013) 0.75
[Multifactorial analysis of the effect of metabolic and endocrine factors on cellular immunity in patients with cancer of the uterine body]. Akush Ginekol (Mosk) (1990) 0.75
[Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system]. Vopr Onkol (2004) 0.75
[Hormonal metabolic status in breast cancer patients after conservative surgery: comparison with known prognostic criteria]. Vopr Onkol (1999) 0.75
[Breast cancer receptor status in smoking and diabetic patients]. Vopr Onkol (2005) 0.75
[Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking]. Vopr Onkol (2000) 0.75
[The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide]. Vopr Onkol (2000) 0.75
[Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence]. Vopr Onkol (2014) 0.75
[Characteristics of the hormonal metabolic status of patients with colonic and rectal cancer]. Eksp Onkol (1988) 0.75
[Induction by ethanol of 'phenomenon of switching estrogen effect' and its correction]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects]. Vopr Onkol (2001) 0.75
[Hormonal-metabolic status of cancer patients with late-onset menopause]. Vopr Onkol (2003) 0.75